Immunome, Inc. financial statements
Immunome, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 6.94M | 10-K |
| Net income | −USD 212.39M | 10-K |
| Cash and equivalents | USD 653.48M | 10-Q |
| Total debt | USD 3.85M | EODHD |